MedPage Today on MSN
How Do We Know Aluminum Adjuvants in Vaccines Are Safe?
Adjuvants help boost the immune response to the antigen in the vaccine, and can also help with dose sparing, according to a ...
A recent study has provided the first side-by-side comparison of how three major COVID-19 vaccine types differ in triggering ...
Shares of several major vaccine makers lost ground Monday following a report U.S. vaccine approval rules could become ...
Woman's World on MSN
New Low-Dose COVID Vaccine May Be More Effective-Is It Right for You?
Have you seen ads for the new low-dose COVID vaccine called mNEXSpike and wondered what it's all about? Us too! So we did ...
‘Chief Medical Officer’s Annual Report 2025: Infections’ was published at 15:00 UK time on Thursday the 4th of December 2025. Prof Andrew Morris: Andrew is the President of the Academy of Medical ...
Sanofi ( SAN:CA) Evercore 8th Annual Healthcare Conference December 2, 2025 11:30 AM EST Thank you guys for being here. Pleasure to have the CEO of Sanofi, but even more importantly, Chairman-elect of ...
In a Phase 1 trial, women responded well to the novel vaccine. More research is needed to determine whether it can stop the ...
Fentanyl overdoses can happen in minutes, and the usual tools respond after the damage is already underway. A proposed ...
A rapid, two-step immune reaction may underlie rare cases of heart inflammation seen after Covid mRNA vaccination, Stanford ...
Novavax (NVAX) rose 3.70% to close at $6.45 on Friday, snapping a seven-session losing streak, with notable drops of 3.38% and 3.50% on November 18 and 19. Novavax now expects to reach profitability ...
News-Medical.Net on MSN
Cleveland Clinic reports promising results for breast cancer vaccine from final Phase 1 data
Cleveland Clinic researchers are presenting final Phase 1 data from their novel study of a vaccine aimed at preventing triple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results